Product Images Losartan Potassium

The text seems to show a comparison between two medications - Atenolol and Losartan. There is also a graph displaying the percentage of patients with a primary endpoint over a 66-month study period. The adjusted risk reduction for the medications is listed at 13%, with a p-value of 0.021.*

This appears to be a graph or chart showing the percentage of patients with fatal or non-fatal stroke during a study conducted over a period of 66 months. The study compared the effectiveness of two drugs, atenolol and losartan, in preventing stroke. The graph displays the percentage of stroke cases over time for each drug. However, without additional information, it is impossible to provide more specific details or conclusions about the study.*

This appears to be a chart showing the risk reduction percentage with Losartan compared to a placebo in a study. It also includes some statistical data indicating a p-value of 0.0225.*

This appears to be a description of medication packaging for Losartan potassium tablets, with a strength of 25mg, produced by West-Ward Pharmaceuticals Corp. The tablets are round and green with an imprint code of "54;277". The package contains 90 tablets with an expiration date of MM/YY and should be stored at room temperature. The NDC number is 7133514391 and the product is a generic version of Cozaar 25mg.*